MSF doctor Dr. Maham Khalid is examining four-year-old Ahmad during a consultation at the MSF-supported Programmatic Management of Drug-Resistant Tuberculosis (PMDT) site in Gujranwala, Punjab.

Photo Credit: Gul Nayab

Press release |

24 March 2026

MSF demands sustained investments and political will to end neglect of children with tuberculosis

1.2 million children have TB worldwide, but nearly half miss diagnosis and treatment

TUBERCULOSIS

Read more

Photo Credit: Gul Nayab

Press release |

30 March 2026

Gilead refuses to sell groundbreaking HIV prevention drug to MSF

In an open letter published today, Doctors Without Borders/Médecins Sans Frontières (MSF) called on the US pharmaceutical corporation Gilead Sciences to immediately sell the organization the game-changing and highly effective HIV prevention medicine, lenacapavir, for use in its medical programs worldwide. Despite multiple requests, the company has refused to sell lenacapavir directly to MSF.

Feature story |

27 March 2026

A mother’s journey: Caring for her children with drug-resistant TB

Issue brief |

26 March 2026

EthiopiaNigeriaSouth Sudan

Antimicrobial Resistance in Conflict-Affected Settings: Field Realities, Operational Challenges & Policy Insights

Interview |

24 March 2026

How TB Treatment Decision Algorithms Help Diagnose Children: A Paediatrician’s Experience

Statement |

20 March 2026

MSF statement at IGWG6

Press release |

19 March 2026

MSF calls on EU to unlock progress in final Pandemic Agreement talks

Letter |

16 March 2026

Open letter: The Critical Medicines Act must deliver equitable, affordable access to medicines for all

Press release |

05 March 2026

DNP+ and MSF welcome the removal of harmful IP provisions in EU-India FTA , but call for continued vigilance

Technical brief |

09 February 2026

Ensuring Collective Efforts Deliver Equitable Access Through the WHO PABS System

Events |

06 February 2026

MSF statements at WHO Executive Board 158th session

Statement |

16 December 2025

Governments must take concrete actions to ensure equitable access to medical tools for noncommunicable diseases and mental health conditions

Press release |

02 December 2025

MSF responds to Novo Nordisk’s discontinuation of key insulin products in EU/EEA

Maria Atonio, 43-years-old farmer from Macomia, returns home after visiting MSF’s Clinic in Nanga to receive ART treatment and to have a medical appointment with MSF’s clinical officer to monitor her health.

Photo credit: MSF/Martim Gray Pereira

Press release |

19 March 2026

MSF calls on EU to unlock progress in final Pandemic Agreement talks

EU must guarantee access to medical tools for communities sharing pathogens and data

PANDEMIC PREPAREDNESS RESEARCH AND DEVELOPMENT

Read more

Photo credit: MSF/Martim Gray Pereira

Press release |

30 March 2026

Gilead refuses to sell groundbreaking HIV prevention drug to MSF

In an open letter published today, Doctors Without Borders/Médecins Sans Frontières (MSF) called on the US pharmaceutical corporation Gilead Sciences to immediately sell the organization the game-changing and highly effective HIV prevention medicine, lenacapavir, for use in its medical programs worldwide. Despite multiple requests, the company has refused to sell lenacapavir directly to MSF.

Feature story |

27 March 2026

A mother’s journey: Caring for her children with drug-resistant TB

Issue brief |

26 March 2026

EthiopiaNigeriaSouth Sudan

Antimicrobial Resistance in Conflict-Affected Settings: Field Realities, Operational Challenges & Policy Insights

Press release |

24 March 2026

MSF demands sustained investments and political will to end neglect of children with tuberculosis

Interview |

24 March 2026

How TB Treatment Decision Algorithms Help Diagnose Children: A Paediatrician’s Experience

Statement |

20 March 2026

MSF statement at IGWG6

Letter |

16 March 2026

Open letter: The Critical Medicines Act must deliver equitable, affordable access to medicines for all

Press release |

05 March 2026

DNP+ and MSF welcome the removal of harmful IP provisions in EU-India FTA , but call for continued vigilance

Technical brief |

09 February 2026

Ensuring Collective Efforts Deliver Equitable Access Through the WHO PABS System

Events |

06 February 2026

MSF statements at WHO Executive Board 158th session

Statement |

16 December 2025

Governments must take concrete actions to ensure equitable access to medical tools for noncommunicable diseases and mental health conditions

Press release |

02 December 2025

MSF responds to Novo Nordisk’s discontinuation of key insulin products in EU/EEA

MSF bio lab at MSF’s Aden hospital controls and treats the anti-resistant infected cases. Aden-The Bio lab project was launched as part of the medical lab at MSF Aden hospital southern Yemen, on January 2017.

Photograph by Ehab Zawati/MSF

Technical brief |

09 February 2026

Ensuring Collective Efforts Deliver Equitable Access Through the WHO PABS System

MSF recommendations on WHO Pathogen Access and Benefit-Sharing (PABS) systems

PANDEMIC PREPAREDNESS

Read more

Photograph by Ehab Zawati/MSF

Press release |

30 March 2026

Gilead refuses to sell groundbreaking HIV prevention drug to MSF

In an open letter published today, Doctors Without Borders/Médecins Sans Frontières (MSF) called on the US pharmaceutical corporation Gilead Sciences to immediately sell the organization the game-changing and highly effective HIV prevention medicine, lenacapavir, for use in its medical programs worldwide. Despite multiple requests, the company has refused to sell lenacapavir directly to MSF.

Feature story |

27 March 2026

A mother’s journey: Caring for her children with drug-resistant TB

Issue brief |

26 March 2026

EthiopiaNigeriaSouth Sudan

Antimicrobial Resistance in Conflict-Affected Settings: Field Realities, Operational Challenges & Policy Insights

Press release |

24 March 2026

MSF demands sustained investments and political will to end neglect of children with tuberculosis

Interview |

24 March 2026

How TB Treatment Decision Algorithms Help Diagnose Children: A Paediatrician’s Experience

Statement |

20 March 2026

MSF statement at IGWG6

Press release |

19 March 2026

MSF calls on EU to unlock progress in final Pandemic Agreement talks

Letter |

16 March 2026

Open letter: The Critical Medicines Act must deliver equitable, affordable access to medicines for all

Press release |

05 March 2026

DNP+ and MSF welcome the removal of harmful IP provisions in EU-India FTA , but call for continued vigilance

Events |

06 February 2026

MSF statements at WHO Executive Board 158th session

Statement |

16 December 2025

Governments must take concrete actions to ensure equitable access to medical tools for noncommunicable diseases and mental health conditions

Press release |

02 December 2025

MSF responds to Novo Nordisk’s discontinuation of key insulin products in EU/EEA

Every three minutes, a child dies of tuberculosis (TB), even though treatment is available. In children, under-diagnosis is a major obstacle to effective treatment. New WHO recommendations, including treatment decision algorithms, could change all that.

Photo Credit: Stuart Tibaweswa

Press release |

18 November 2025

MSF findings show WHO algorithms could double the number of children diagnosed and treated for TB

Governments must act now to ensure no child is left behind in the fight against this deadly disease

TUBERCULOSIS

Read more

Photo Credit: Stuart Tibaweswa

Press release |

30 March 2026

Gilead refuses to sell groundbreaking HIV prevention drug to MSF

In an open letter published today, Doctors Without Borders/Médecins Sans Frontières (MSF) called on the US pharmaceutical corporation Gilead Sciences to immediately sell the organization the game-changing and highly effective HIV prevention medicine, lenacapavir, for use in its medical programs worldwide. Despite multiple requests, the company has refused to sell lenacapavir directly to MSF.

Feature story |

27 March 2026

A mother’s journey: Caring for her children with drug-resistant TB

Issue brief |

26 March 2026

EthiopiaNigeriaSouth Sudan

Antimicrobial Resistance in Conflict-Affected Settings: Field Realities, Operational Challenges & Policy Insights

Press release |

24 March 2026

MSF demands sustained investments and political will to end neglect of children with tuberculosis

Interview |

24 March 2026

How TB Treatment Decision Algorithms Help Diagnose Children: A Paediatrician’s Experience

Statement |

20 March 2026

MSF statement at IGWG6

Press release |

19 March 2026

MSF calls on EU to unlock progress in final Pandemic Agreement talks

Letter |

16 March 2026

Open letter: The Critical Medicines Act must deliver equitable, affordable access to medicines for all

Press release |

05 March 2026

DNP+ and MSF welcome the removal of harmful IP provisions in EU-India FTA , but call for continued vigilance

Technical brief |

09 February 2026

Ensuring Collective Efforts Deliver Equitable Access Through the WHO PABS System

Events |

06 February 2026

MSF statements at WHO Executive Board 158th session

Statement |

16 December 2025

Governments must take concrete actions to ensure equitable access to medical tools for noncommunicable diseases and mental health conditions

Latest News

MSF protests at International AIDS Conference asking for price reduction for CAB-LA and LEN-LA

Press release |

30 March 2026

HIV/AIDS

Gilead refuses to sell groundbreaking HIV prevention drug to MSF

MSF doctor Dr. Maham Khalid interacts with the mother of five-year-old Hareem and four-year-old Ahmad during a consultation at the MSF-supported Programmatic Management of Drug-Resistant Tuberculosis (PMDT) site in Gujranwala, Punjab.

Photo Credit: Gul Nayab

Feature story |

27 March 2026

A mother’s journey: Caring for her children with drug-resistant TB

2 min

Issue brief

Issue brief |

26 March 2026

Antimicrobial resistance

EthiopiaNigeriaSouth Sudan

Antimicrobial Resistance in Conflict-Affected Settings: Field Realities, Operational Challenges & Policy Insights

MSF doctor Dr. Maham Khalid is examining four-year-old Ahmad during a consultation at the MSF-supported Programmatic Management of Drug-Resistant Tuberculosis (PMDT) site in Gujranwala, Punjab.

Photo Credit: Gul Nayab

Press release |

24 March 2026

MSF demands sustained investments and political will to end neglect of children with tuberculosis

5 min

Abu Al-Fadl, a young boy diagnosed early with tuberculosis, sits with his father and an MSF health promoter at Mustafa Al-Adhari Health Center in Sadr City. After completing his treatment, he has recovered and will soon return to school..

Photo Credit: Deniz Fahmi/MSF

Interview |

24 March 2026

How TB Treatment Decision Algorithms Help Diagnose Children: A Paediatrician’s Experience

3 min

WHO Executive Board's Special Session on Ebola

UN Photo/Christopher Black

Statement |

20 March 2026

Pandemic preparedness

MSF statement at IGWG6

1 min

Maria Atonio, 43-years-old farmer from Macomia, returns home after visiting MSF’s Clinic in Nanga to receive ART treatment and to have a medical appointment with MSF’s clinical officer to monitor her health.

Photo credit: MSF/Martim Gray Pereira

Press release |

19 March 2026

Pandemic preparedness Research and development

MSF calls on EU to unlock progress in final Pandemic Agreement talks

2 min

Letter

Letter |

16 March 2026

Research and development

Open letter: The Critical Medicines Act must deliver equitable, affordable access to medicines for all

AC20 Lives over profit video

Video

Lives Over Profit: a Patient, a Doctor and a Lawyer Take Action

Read more

100 years of insulin

Video |

14 April 2021

100 years of insulin

Read more

A Snapshot of the Access Campaign in 2017

Video

A Snapshot of the Access Campaign

Read more

Video thumbnail

Lives Over Profit: a Patient, a Doctor and a Lawyer Take Action

Video thumbnail

100 years of insulin

Video thumbnail

A Snapshot of the Access Campaign

Our work

Drug-resistant infections

Tropical & neglected diseases

Patents & intellectual property

Research & development